2023-08-03 01:58:10 ET
- Bridge to Life will divest certain assets to TransMedics ( NASDAQ: TMDX ), a wholly owned subsidiary of TransMedics Group including its EVOSS heart and lung and LifeCradle heart perfusion assets.
- BTL will use the proceeds from the divestiture of these assets to focus on its core preservation solutions business and its pending FDA submission for the VitaSmart Liver Machine Perfusion System.
- TMDX stock price is up 3.1% during after hours on Wednesday.
For further details see:
TransMedics rises 3% on asset acquisition from Bridge to Life